110 results
Page 2 of 6
8-K
EX-99.1
g3yt djrx7ms
3 Aug 21
Alnylam Pharmaceuticals Reports Second Quarter 2021 Financial Results and Highlights
8:10am
8-K
EX-99.1
ff673x tro2jbib3ndb
29 Apr 21
Results of Operations and Financial Condition
8:12am
8-K
EX-99.1
55kdvgmbhnq4gmomjk
11 Feb 21
Results of Operations and Financial Condition
8:10am
8-K
EX-99.1
l2f541en
11 Jan 21
Alnylam Launches “Alnylam P5x25” Strategy for Planned Transition to a Top Five Biotech in Market Capitalization Over Next Five Years
8:37am
8-K
EX-99.1
kxkvym ckdt2gdv1uu
5 Nov 20
Results of Operations and Financial Condition
8:10am
8-K
EX-99.2
npz9uk7
6 Aug 20
Results of Operations and Financial Condition
8:10am
8-K
EX-99.1
e5lax
6 Aug 20
Results of Operations and Financial Condition
8:10am
8-K
EX-99.1
okjw1nzv
6 May 20
Results of Operations and Financial Condition
8:10am
8-K
EX-99.1
w9nrhl1qnozil
13 Apr 20
Blackstone and Alnylam Enter Into $2 Billion Strategic Financing Collaboration to
4:22pm
8-K
EX-99.1
i4kp8wxkycq 8vs
6 Feb 20
Results of Operations and Financial Condition
8:28am
8-K
EX-99.1
m05k59z
31 Oct 19
Results of Operations and Financial Condition
8:10am
8-K
EX-99.1
3qdv4grp0xjb1jjk2y
6 Aug 19
Results of Operations and Financial Condition
8:15am
8-K
EX-99.1
42g529kg1g1u3b picnr
1 May 19
Alnylam Pharmaceuticals Reports First Quarter 2019 Financial Results and Highlights Recent Period Activity
8:45am
8-K
EX-99.1
ngghms
7 Feb 19
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Recent Period Activity
4:15pm
424B5
dna15g
15 Jan 19
Prospectus supplement for primary offering
5:14pm